395 related articles for article (PubMed ID: 30219060)
1. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
Mahmoud MY; Demuth DR; Steinbach-Rankins JM
J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
[TBL] [Abstract][Full Text] [Related]
2. Peptide-modified nanoparticles inhibit formation of
Kalia P; Jain A; Radha Krishnan R; Demuth DR; Steinbach-Rankins JM
Int J Nanomedicine; 2017; 12():4553-4562. PubMed ID: 28790818
[TBL] [Abstract][Full Text] [Related]
3. Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.
Mahmoud MY; Steinbach-Rankins JM; Demuth DR
J Control Release; 2019 Mar; 297():3-13. PubMed ID: 30690103
[TBL] [Abstract][Full Text] [Related]
4. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii.
Daep CA; Novak EA; Lamont RJ; Demuth DR
Infect Immun; 2011 Jan; 79(1):67-74. PubMed ID: 21041492
[TBL] [Abstract][Full Text] [Related]
5. Rapid Release Polymeric Fibers for Inhibition of
Mahmoud MY; Sapare S; Curry KC; Demuth DR; Steinbach-Rankins JM
Front Chem; 2019; 7():926. PubMed ID: 32039149
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation.
Daep CA; James DM; Lamont RJ; Demuth DR
Infect Immun; 2006 Oct; 74(10):5756-62. PubMed ID: 16988253
[TBL] [Abstract][Full Text] [Related]
7. Tobacco smoke augments Porphyromonas gingivalis-Streptococcus gordonii biofilm formation.
Bagaitkar J; Daep CA; Patel CK; Renaud DE; Demuth DR; Scott DA
PLoS One; 2011; 6(11):e27386. PubMed ID: 22110637
[TBL] [Abstract][Full Text] [Related]
8. Natural antigenic differences in the functionally equivalent extracellular DNABII proteins of bacterial biofilms provide a means for targeted biofilm therapeutics.
Rocco CJ; Davey ME; Bakaletz LO; Goodman SD
Mol Oral Microbiol; 2017 Apr; 32(2):118-130. PubMed ID: 26988714
[TBL] [Abstract][Full Text] [Related]
9. Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates.
Lamont RJ; El-Sabaeny A; Park Y; Cook GS; Costerton JW; Demuth DR
Microbiology (Reading); 2002 Jun; 148(Pt 6):1627-1636. PubMed ID: 12055284
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Porphyromonas gingivalis with oral streptococci requires a motif that resembles the eukaryotic nuclear receptor box protein-protein interaction domain.
Daep CA; Lamont RJ; Demuth DR
Infect Immun; 2008 Jul; 76(7):3273-80. PubMed ID: 18474648
[TBL] [Abstract][Full Text] [Related]
11. Role of gallium and silver from phosphate-based glasses on in vitro dual species oral biofilm models of Porphyromonas gingivalis and Streptococcus gordonii.
Valappil SP; Coombes M; Wright L; Owens GJ; Lynch RJ; Hope CK; Higham SM
Acta Biomater; 2012 May; 8(5):1957-65. PubMed ID: 22314314
[TBL] [Abstract][Full Text] [Related]
12. 1,2,3-Triazole-based inhibitors of Porphyromonas gingivalis adherence to oral streptococci and biofilm formation.
Patil PC; Tan J; Demuth DR; Luzzio FA
Bioorg Med Chem; 2016 Nov; 24(21):5410-5417. PubMed ID: 27647373
[TBL] [Abstract][Full Text] [Related]
13. Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms.
Desai H; Mahmoud MY; Tan J; Minooei F; Demuth DR; Steinbach-Rankins JM
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32882864
[No Abstract] [Full Text] [Related]
14. Selective substitution of amino acids limits proteolytic cleavage and improves the bioactivity of an anti-biofilm peptide that targets the periodontal pathogen, Porphyromonas gingivalis.
Daep CA; Novak EA; Lamont RJ; Demuth DR
Peptides; 2010 Dec; 31(12):2173-8. PubMed ID: 20800634
[TBL] [Abstract][Full Text] [Related]
15. Erythritol alters microstructure and metabolomic profiles of biofilm composed of Streptococcus gordonii and Porphyromonas gingivalis.
Hashino E; Kuboniwa M; Alghamdi SA; Yamaguchi M; Yamamoto R; Cho H; Amano A
Mol Oral Microbiol; 2013 Dec; 28(6):435-51. PubMed ID: 23890177
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activities of natural lichen compounds against Streptococcus gordonii and Porphyromonas gingivalis.
Sweidan A; Chollet-Krugler M; Sauvager A; van de Weghe P; Chokr A; Bonnaure-Mallet M; Tomasi S; Bousarghin L
Fitoterapia; 2017 Sep; 121():164-169. PubMed ID: 28736072
[TBL] [Abstract][Full Text] [Related]
17. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
Rocco CJ; Bakaletz LO; Goodman SD
J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850
[TBL] [Abstract][Full Text] [Related]
18. The effect of lactoferrin on oral bacterial attachment.
Arslan SY; Leung KP; Wu CD
Oral Microbiol Immunol; 2009 Oct; 24(5):411-6. PubMed ID: 19702956
[TBL] [Abstract][Full Text] [Related]
19. Disruption of heterotypic community development by Porphyromonas gingivalis with small molecule inhibitors.
Wright CJ; Wu H; Melander RJ; Melander C; Lamont RJ
Mol Oral Microbiol; 2014 Oct; 29(5):185-93. PubMed ID: 24899524
[TBL] [Abstract][Full Text] [Related]
20.
Tan J; Patil PC; Luzzio FA; Demuth DR
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
